Methods of treating advanced prostate cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11541062
APP PUB NO 20200188416A1
SERIAL NO

16787589

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods for treating metastatic prostate cancer using anti-androgen compounds and radionuclide-labeled androgens.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BECKMAN RESEARCH INSTITUTE CITY OF HOPE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Horne, David Duarte, US 96 481
Li, Junfeng Duarte, US 90 483
Shively, John E Duarte, US 33 137
Sun, Zijie Duarte, US 2 1
Xie, Jun Duarte, US 165 1402

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 3, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 3, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 3, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00